190 related articles for article (PubMed ID: 15275951)
21. Pro- and anti-inflammatory cytokine gene polymorphism profiles in Bulgarian multiple sclerosis patients.
Mihailova S; Ivanova M; Mihaylova A; Quin L; Mikova O; Naumova E
J Neuroimmunol; 2005 Nov; 168(1-2):138-43. PubMed ID: 16183136
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis.
Osoegawa M; Miyagishi R; Ochi H; Nakamura I; Niino M; Kikuchi S; Murai H; Fukazawa T; Minohara M; Tashiro K; Kira J
J Neuroimmunol; 2005 Apr; 161(1-2):195-8. PubMed ID: 15748960
[TBL] [Abstract][Full Text] [Related]
23. CRYAB promoter polymorphisms: influence on multiple sclerosis susceptibility and clinical presentation.
Stoevring B; Frederiksen JL; Christiansen M
Clin Chim Acta; 2007 Jan; 375(1-2):57-62. PubMed ID: 17010329
[TBL] [Abstract][Full Text] [Related]
24. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.
Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
J Affect Disord; 2011 Mar; 129(1-3):175-82. PubMed ID: 20888049
[TBL] [Abstract][Full Text] [Related]
25. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?
Núñez C; Dema B; Cénit MC; Polanco I; Maluenda C; Arroyo R; de las Heras V; Bartolomé M; de la Concha EG; Urcelay E; Martínez A
Genes Immun; 2008 Jun; 9(4):289-93. PubMed ID: 18368064
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha gene polymorphisms in children with multiple sclerosis.
Anlar B; Alikaşifoglu M; Köse G; Güven A; Gürer Y; Yakut A
Neuropediatrics; 2001 Aug; 32(4):214-6. PubMed ID: 11571703
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases.
Holla LI; Stejskalova A; Znojil V; Vasku A
Clin Exp Allergy; 2006 Dec; 36(12):1592-601. PubMed ID: 17177683
[TBL] [Abstract][Full Text] [Related]
28. Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.
Braun N; Michel U; Ernst BP; Metzner R; Bitsch A; Weber F; Rieckmann P
Neurosci Lett; 1996 Sep; 215(2):75-8. PubMed ID: 8887999
[TBL] [Abstract][Full Text] [Related]
29. Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population.
Tajouri L; Fernandez F; Tajouri S; Detriche G; Szvetko A; Colson N; Csurhes P; Pender MP; Griffiths LR
J Neurol Sci; 2007 Jan; 252(1):9-12. PubMed ID: 17109894
[TBL] [Abstract][Full Text] [Related]
30. A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis.
Gómez LM; Anaya JM; Vilchez JR; Cadena J; Hinojosa R; Vélez L; Lopez-Nevot MA; Martín J
Tuberculosis (Edinb); 2007 Jul; 87(4):288-94. PubMed ID: 17475563
[TBL] [Abstract][Full Text] [Related]
31. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
32. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis.
Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF
J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378
[TBL] [Abstract][Full Text] [Related]
33. Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease.
Morris BJ; Glenn CL; Wilcken DE; Wang XL
Clin Sci (Lond); 2001 May; 100(5):551-6. PubMed ID: 11294696
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis.
Kroner A; Mäurer M; Loserth S; Kleinschnitz C; Hemmer B; Rosche B; Toyka KV; Rieckmann P
Tissue Antigens; 2004 Jul; 64(1):70-3. PubMed ID: 15191525
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension.
Rutherford S; Johnson MP; Curtain RP; Griffiths LR
Hum Genet; 2001 Oct; 109(4):408-15. PubMed ID: 11702222
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the stathmin rs182455 single nucleotide promoter polymorphism in patients with multiple sclerosis.
Buttmann M; Nowak E; Kroner A; Hemmer B; Lesch KP; Rieckmann P
J Neurogenet; 2008; 22(3):181-6. PubMed ID: 19012073
[TBL] [Abstract][Full Text] [Related]
37. Endothelial nitric oxide synthase gene polymorphism is associated with Behçet's disease in Tunisian population.
Ben Dhifallah I; Houman H; Khanfir M; Hamzaoui K
Hum Immunol; 2008 Oct; 69(10):661-5. PubMed ID: 18718857
[TBL] [Abstract][Full Text] [Related]
38. No evidence for linkage in the promoter region of the inducible nitric oxide synthase gene (NOS2) in a Danish type 1 diabetes population.
Johannesen J; Pociot F; Kristiansen OP; Karlsen AE; Nerup J;
Genes Immun; 2000 Aug; 1(6):362-6. PubMed ID: 11196682
[TBL] [Abstract][Full Text] [Related]
39. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease.
Cattaruzza M; Guzik TJ; Słodowski W; Pelvan A; Becker J; Halle M; Buchwald AB; Channon KM; Hecker M
Circ Res; 2004 Oct; 95(8):841-7. PubMed ID: 15375006
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study.
La Russa A; Cittadella R; De Marco EV; Valentino P; Andreoli V; Trecroci F; Latorre V; Gambardella A; Quattrone A
J Neuroimmunol; 2010 Aug; 225(1-2):175-9. PubMed ID: 20471697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
